Other languages Shandong Boan Biotechnology Co., Ltd.

Equities

6955

CNE100005RV4

Market Closed - Hong Kong S.E. Other stock markets 04:08:17 2024-05-17 am EDT			5-day change	1st Jan Change
9.97 ^HKD	-0.10%		-0.89%	-35.68%

Apr. 12	Shandong Boan Biotechnology Co., Ltd. Enters into Loan Facility with China Jingu International Trust Co., Ltd	CI
Apr. 08	Shandong Boan Biotechnology Completes Phase 3 Trial for Retina Injection	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shandong Boan Biotechnology Completes Phase 3 Trial for Retina Injection	Apr. 08
Shandong Boan Biotechnology Co., Ltd. Completes Phase 3 Clinical Trial in China for Aflibercept Intravitreous Injection and Plans to Submit Biologics License Application	Apr. 08
Ocumension Therapeutics' Eye Drug Completes Clinical Trials, to Apply for NDA Soon	Apr. 08
Shandong Boan Biotechnology Trims Attributable Loss in 2023	Mar. 26
Shandong Boan Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25
Shandong Boan Biotech Completes Phase 3 Trial for Type 2 Diabetes Injection; Shares Surge 10%	Mar. 08
Shandong Boan Biotechnology Co., Ltd. Announces Phase 3 Clinical Trial Completed in China for Dulaglutide Injection	Mar. 07
Shandong Boan Biotechnology Authorizes CDMO Service Provider to Use Stable Cell Line Development Platform	Jan. 30
Shandong Boan Biotechnology Co., Ltd. Enters into Agreement with the Zencore Biologics Co., Ltd	Jan. 29
Boan Biotechnology, Joincare Sign Exclusive License Deal for Respiratory Disease Treatment	Jan. 29
Shandong Boan Biotechnology Co., Ltd. Announces Orphan Drug Designations for Treatment of Gastric Cancer by FDA	Jan. 24
Shandong Boan Biotechnology Co., Ltd. Obtains GMP Certification for Boyuno®? from the Brazilian Agencia Nacional De Vigilancia Sanitaria	Jan. 17
Boan Biotech Completes Enrollment for International Multicenter Comparative Clinical (Phase 3) Study of Its Denosumab	Jan. 12
Shandong Boan Biotechnology Co., Ltd. Announces Resignation of Chen Jie as Non-Executive Director	Dec. 12
Boan Biotech Announces First Patient Enrolled in Phase III Clinical Trial of Boan Biotech's Nivolumab Injection	23-10-30
Shandong Boan Biotechnology's H1 Attributable Loss Narrows; Shares Fall 7%	23-09-21
Shandong Boan Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-27
Shandong Boan Biotechnology Co., Ltd. Announces Approval for Injection for the Novel Bi-Specific Antibody BA1202	23-05-16
Shandong Boan Biotechnology Co., Ltd. Announces Patient Enrollment Completion for the Phase III Clinical Trial of BA5101 in China	23-05-15
Shandong Boan Biotechnology Co., Ltd. Initiates an International Multi-Center Phase 3 Clinical Study in Europe, the United States, and Japan	23-05-04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Shandong Boan Biotechnology Co., Ltd.

Equities

6955

CNE100005RV4

Other languages

Filters